13 Oct 2026Sun Pharmaceutical Industries Ltd credit rating assigned Crisil AAA/Stable for NCDs and reaffirmed by CRISIL/ICRA on 13 Oct 2026Credit Ratings
12 Oct 2026Sun Pharmaceutical Industries Ltd accepts resignation of Mr. Gautam Doshi as Independent Director on 12 Oct 2026KMP
7 Oct 2026Sun Pharmaceutical Industries Ltd board meeting scheduled on 12 Oct 2026 to consider NCD issuanceCapital Raise
2 Oct 2026Sun Pharmaceutical Industries Ltd intimation of newspaper advertisement for postal ballot/e-voting notice published on 02 Oct 2026Capital Raise
1 Oct 2026Sun Pharmaceutical Industries Ltd notice of postal ballot/e-voting for ESOP 2026 and other approvals; voting opens 02 Oct 2026Record Date
28 Sept 2026Sun Pharmaceutical Industries Ltd outcome of postal ballot dated 25 Aug 2026; resolution approved on 26 Sep 2026Record Date
28 Sept 2026Sun Pharmaceutical Industries Ltd announces global licensing and manufacturing agreement with LIB Therapeutics for LerodalcibepMOU
8 Sept 2026Sun Pharmaceutical Industries Ltd credit rating assigned: Baa1 by Moody's and BBB+ by S&P Global on 08 Sep 2026Credit Ratings
1 Sept 2026Sun Pharmaceutical Industries Ltd press release dated 01 Sep 2026 on participation in White House signing ceremony for U.S. medicines pricing commitmentsMOU
26 Aug 2026Sun Pharmaceutical Industries Ltd intimation of newspaper advertisements published on 26 August 2026 containing information about postal ballot/e-votingRecord Date
25 Aug 2026Sun Pharmaceutical Industries Ltd postal ballot notice for reclassification of promoter group to public categoryRecord Date
20 May 2026Sun Pharmaceutical Industries Limited notification about SEBI special window for transfer of physical shares under Regulation 30 scheduled on 20 May 2026Record Date
